BERNS PAUL L (CIK 1202769) reported 12 SEC Form 4 insider transactions across 4 companies over the past 18 months (most recent 2026-06-24). Recent activity: Buy KARD (1.2M shares), Buy KARD (13.8M shares), Buy KARD (20,706 shares), Buy LYEL (488,090 shares), Sell NMRA (9,819 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-24 | Kardigan, Inc. (KARD) | Director | Buy | 1.2M | $20.0M |
| 2026-06-22 | Kardigan, Inc. (KARD) | Director | Buy | 13.8M | $0 |
| 2026-06-22 | Kardigan, Inc. (KARD) | Director | Buy | 20,706 | $0 |
| 2026-03-09 | Lyell Immunopharma, Inc. (LYEL) | Insider | Buy | 488,090 | $12.5M |
| 2026-02-19 | Neumora Therapeutics, Inc. (NMRA) | See Remarks | Sell | 9,819 | $34,465 |
| 2025-11-13 | Metsera, Inc. (MTSR) | Director | Sell | 4,031 | $0 |
| 2025-11-13 | Metsera, Inc. (MTSR) | Director | Sell | 7.5M | $0 |
| 2025-11-13 | Metsera, Inc. (MTSR) | Director | Sell | 8.3M | $0 |
| 2025-11-13 | Metsera, Inc. (MTSR) | Director | Sell | 957,559 | $0 |
| 2025-02-20 | Neumora Therapeutics, Inc. (NMRA) | See Remarks | Sell | 13,871 | $23,442 |
| 2025-02-03 | Metsera, Inc. (MTSR) | Director | Buy | 7.5M | $0 |
| 2025-02-03 | Metsera, Inc. (MTSR) | Director | Buy | 789,998 | $14.2M |
Source: SEC Form 4 filings · as of 2026-06-24